lgE-话题@MedSci

#lgE#

48篇内容 | 1064人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1539240, encodeId=bf4715392407e, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=两名儿童接受最贵的基因治疗药物Zolgensma治疗后死于肝功能衰竭，正在调查原因, objectType=article, longId=735707, objectId=5082e35707b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5082e35707b6, replyNumber=0, likeNumber=34, createdTime=2022-08-14, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5082e35707b6, moduleTitle=两名儿童接受最贵的基因治疗药物Zolgensma治疗后死于肝功能衰竭，正在调查原因, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5082e35707b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539239, encodeId=fc4b15392396e, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=European Radiology：iNAV三维心肌Dixon LGE成像在临床中的应用, objectType=article, longId=726224, objectId=25f7e2622462, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25f7e2622462, replyNumber=0, likeNumber=43, createdTime=2022-05-07, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25f7e2622462, moduleTitle=European Radiology：iNAV三维心肌Dixon LGE成像在临床中的应用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25f7e2622462)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539238, encodeId=7eed1539238ed, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=1348万Zolgensma，一针治愈遗传病脊髓性肌萎缩症（SMA）, objectType=article, longId=294923, objectId=f98b294923a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f98b294923a6, replyNumber=0, likeNumber=45, createdTime=2022-02-01, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f98b294923a6, moduleTitle=1348万Zolgensma，一针治愈遗传病脊髓性肌萎缩症（SMA）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f98b294923a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539237, encodeId=0a3b153923e32, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=SpeeDx和MolGen宣布合作开发新冠病毒检测解决方案, objectType=article, longId=213636, objectId=aa21213636e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa21213636e3, replyNumber=0, likeNumber=43, createdTime=2021-07-04, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa21213636e3, moduleTitle=SpeeDx和MolGen宣布合作开发新冠病毒检测解决方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa21213636e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539236, encodeId=a20c153923603, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=Anesthesia & Analgesia：术中高流量鼻氧的有效性:一项系统回顾和Meta分析, objectType=article, longId=213577, objectId=4ac02135e766, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ac02135e766, replyNumber=0, likeNumber=28, createdTime=2021-07-02, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ac02135e766, moduleTitle=Anesthesia & Analgesia：术中高流量鼻氧的有效性:一项系统回顾和Meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ac02135e766)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539235, encodeId=d40a15392355f, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=JAMA Neurol：Zolgensma治疗后5年，脊髓性肌肉萎缩症患者仍可获得长期临床缓解, objectType=article, longId=211985, objectId=93e021198556, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93e021198556, replyNumber=0, likeNumber=26, createdTime=2021-05-30, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93e021198556, moduleTitle=JAMA Neurol：Zolgensma治疗后5年，脊髓性肌肉萎缩症患者仍可获得长期临床缓解, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93e021198556)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539234, encodeId=54841539234c3, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=Laryngoscope：lgE的早期反应能够预测舌下免疫治疗的满意度 , objectType=article, longId=197466, objectId=6b3a19e46660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b3a19e46660, replyNumber=0, likeNumber=39, createdTime=2020-07-15, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b3a19e46660, moduleTitle=Laryngoscope：lgE的早期反应能够预测舌下免疫治疗的满意度 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b3a19e46660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539233, encodeId=4de215392333d, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=诺华的天价基因疗法Zolgensma，在欧洲获批治疗脊柱性肌肉萎缩症, objectType=article, longId=194459, objectId=50e81944593f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50e81944593f, replyNumber=0, likeNumber=31, createdTime=2020-05-22, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50e81944593f, moduleTitle=诺华的天价基因疗法Zolgensma，在欧洲获批治疗脊柱性肌肉萎缩症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50e81944593f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539232, encodeId=a170153923298, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=J Exp Clin Cancer Res：MAZ通过转录激活KRas依赖性的RalGEFs通路促进前列腺癌骨转移, objectType=article, longId=192934, objectId=0ff21929347b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ff21929347b, replyNumber=0, likeNumber=37, createdTime=2020-04-26, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ff21929347b, moduleTitle=J Exp Clin Cancer Res：MAZ通过转录激活KRas依赖性的RalGEFs通路促进前列腺癌骨转移, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ff21929347b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539231, encodeId=450015392319f, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=5年随访数据证明Zolgensma基因疗法针对脊髓性肌萎缩症的安全性和有效性, objectType=article, longId=190825, objectId=4f7c19082592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f7c19082592, replyNumber=0, likeNumber=38, createdTime=2020-03-27, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f7c19082592, moduleTitle=5年随访数据证明Zolgensma基因疗法针对脊髓性肌萎缩症的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f7c19082592)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539230, encodeId=e5131539230e2, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=诺华的基因疗法Zolgensma，在日本获批治疗脊髓性肌萎缩症（SMA）儿童患者, objectType=article, longId=190503, objectId=eb4819050376, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb4819050376, replyNumber=0, likeNumber=42, createdTime=2020-03-22, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb4819050376, moduleTitle=诺华的基因疗法Zolgensma，在日本获批治疗脊髓性肌萎缩症（SMA）儿童患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb4819050376)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539229, encodeId=770b1539229d3, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=Algernon已提交Pre-IND申请，以进行Ifenprodil治疗新冠肺炎的临床试验, objectType=article, longId=190020, objectId=b9e3190020b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9e3190020b9, replyNumber=0, likeNumber=54, createdTime=2020-03-16, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9e3190020b9, moduleTitle=Algernon已提交Pre-IND申请，以进行Ifenprodil治疗新冠肺炎的临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9e3190020b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539228, encodeId=95461539228b6, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=Algernon正在探索将Ifenprodil用作COVID-19冠状病毒的新型疗法，小鼠实验中该药物具有显着降低急性肺损伤的作用, objectType=article, longId=189584, objectId=fe9818958401, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe9818958401, replyNumber=0, likeNumber=35, createdTime=2020-03-10, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe9818958401, moduleTitle=Algernon正在探索将Ifenprodil用作COVID-19冠状病毒的新型疗法，小鼠实验中该药物具有显着降低急性肺损伤的作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe9818958401)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539227, encodeId=1f18153922e8e, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=Pediatr Allergy Immunol：季节过敏性鼻炎儿童和成年鼻分泌物中lgE抗体谱分析, objectType=article, longId=184304, objectId=a94318430492, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a94318430492, replyNumber=0, likeNumber=36, createdTime=2019-12-07, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a94318430492, moduleTitle=Pediatr Allergy Immunol：季节过敏性鼻炎儿童和成年鼻分泌物中lgE抗体谱分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a94318430492)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539226, encodeId=fb20153922650, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=Celgene的Reblozyl成为美国针对β地中海贫血的治疗药物, objectType=article, longId=182744, objectId=f017182e4470, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f017182e4470, replyNumber=0, likeNumber=35, createdTime=2019-11-11, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f017182e4470, moduleTitle=Celgene的Reblozyl成为美国针对β地中海贫血的治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f017182e4470)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539225, encodeId=1e1b153922515, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=FDA暂时搁置了对鞘内施用SMA基因疗法Zolgensma的研究, objectType=article, longId=182191, objectId=2b0518219190, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b0518219190, replyNumber=0, likeNumber=48, createdTime=2019-11-01, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b0518219190, moduleTitle=FDA暂时搁置了对鞘内施用SMA基因疗法Zolgensma的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b0518219190)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539224, encodeId=f36f15392246c, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=Anesthesia & Analgesia：静脉注射利多卡因预防围术期咳嗽：系统评价与回顾性分析, objectType=article, longId=178199, objectId=b86a1e819922, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b86a1e819922, replyNumber=0, likeNumber=32, createdTime=2019-08-27, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b86a1e819922, moduleTitle=Anesthesia & Analgesia：静脉注射利多卡因预防围术期咳嗽：系统评价与回顾性分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b86a1e819922)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539223, encodeId=c203153922336, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=FDA批准Celgene的JAK2抑制剂Inrebic治疗骨髓纤维化, objectType=article, longId=177980, objectId=fe551e798093, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe551e798093, replyNumber=0, likeNumber=33, createdTime=2019-08-21, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe551e798093, moduleTitle=FDA批准Celgene的JAK2抑制剂Inrebic治疗骨髓纤维化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe551e798093)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539222, encodeId=69ce15392220b, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=Celgene的Otezla成为美国**白塞病综合征口腔溃疡的治疗方法, objectType=article, longId=175825, objectId=81f01e5825f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81f01e5825f0, replyNumber=0, likeNumber=37, createdTime=2019-07-22, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81f01e5825f0, moduleTitle=Celgene的Otezla成为美国**白塞病综合征口腔溃疡的治疗方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81f01e5825f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1539221, encodeId=c4f515392215b, content=<a href='/topic/show?id=6505108534a' target=_blank style='color:#2F92EE;'>#lgE#</a>, objectTitle=EBioMedicine：IL-2响应的减少与总lgE水平提高和过敏性鼻炎的加重相关, objectType=article, longId=166433, objectId=55eb166433ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55eb166433ae, replyNumber=0, likeNumber=43, createdTime=2019-05-22, rootId=0, userName=HNYYM, userId=beb613117181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55eb166433ae, moduleTitle=EBioMedicine：IL-2响应的减少与总lgE水平提高和过敏性鼻炎的加重相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55eb166433ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

lgE

2020-05-29

HNYYM (审核中...)

前往app查看评论内容

#lgE#

两名儿童接受最贵的基因治疗药物Zolgensma治疗后死于肝功能衰竭，正在调查原因

2022-08-14

HNYYM (审核中...)

前往app查看评论内容

#lgE#

European Radiology：iNAV三维心肌Dixon LGE成像在临床中的应用

2022-05-07

HNYYM (审核中...)

前往app查看评论内容

#lgE#

1348万Zolgensma，一针治愈遗传病脊髓性肌萎缩症（SMA）

2022-02-01

HNYYM (审核中...)

前往app查看评论内容

#lgE#

SpeeDx和MolGen宣布合作开发新冠病毒检测解决方案

2021-07-04

HNYYM (审核中...)

前往app查看评论内容

#lgE#

Anesthesia & Analgesia：术中高流量鼻氧的有效性:一项系统回顾和Meta分析

2021-07-02

HNYYM (审核中...)

前往app查看评论内容

#lgE#

JAMA Neurol：Zolgensma治疗后5年，脊髓性肌肉萎缩症患者仍可获得长期临床缓解

2021-05-30

HNYYM (审核中...)

前往app查看评论内容

#lgE#

Laryngoscope：lgE的早期反应能够预测舌下免疫治疗的满意度

2020-07-15

HNYYM (审核中...)

前往app查看评论内容

#lgE#

诺华的天价基因疗法Zolgensma，在欧洲获批治疗脊柱性肌肉萎缩症

2020-05-22

HNYYM (审核中...)

前往app查看评论内容

#lgE#

J Exp Clin Cancer Res：MAZ通过转录激活KRas依赖性的RalGEFs通路促进前列腺癌骨转移

2020-04-26

HNYYM (审核中...)

前往app查看评论内容

#lgE#

5年随访数据证明Zolgensma基因疗法针对脊髓性肌萎缩症的安全性和有效性

2020-03-27

HNYYM (审核中...)

前往app查看评论内容

#lgE#

诺华的基因疗法Zolgensma，在日本获批治疗脊髓性肌萎缩症（SMA）儿童患者

2020-03-22

HNYYM (审核中...)

前往app查看评论内容

#lgE#

Algernon已提交Pre-IND申请，以进行Ifenprodil治疗新冠肺炎的临床试验

2020-03-16

HNYYM (审核中...)

前往app查看评论内容

#lgE#

Algernon正在探索将Ifenprodil用作COVID-19冠状病毒的新型疗法，小鼠实验中该药物具有显着降低急性肺损伤的作用

2020-03-10

HNYYM (审核中...)

前往app查看评论内容

#lgE#

Pediatr Allergy Immunol：季节过敏性鼻炎儿童和成年鼻分泌物中lgE抗体谱分析

2019-12-07

HNYYM (审核中...)

前往app查看评论内容

#lgE#

Celgene的Reblozyl成为美国针对β地中海贫血的治疗药物

2019-11-11

HNYYM (审核中...)

前往app查看评论内容

#lgE#

FDA暂时搁置了对鞘内施用SMA基因疗法Zolgensma的研究

2019-11-01

HNYYM (审核中...)

前往app查看评论内容

#lgE#

Anesthesia & Analgesia：静脉注射利多卡因预防围术期咳嗽：系统评价与回顾性分析

2019-08-27

HNYYM (审核中...)

前往app查看评论内容

#lgE#

FDA批准Celgene的JAK2抑制剂Inrebic治疗骨髓纤维化

2019-08-21

HNYYM (审核中...)

前往app查看评论内容

#lgE#

Celgene的Otezla成为美国**白塞病综合征口腔溃疡的治疗方法

2019-07-22

HNYYM (审核中...)

前往app查看评论内容

#lgE#

EBioMedicine：IL-2响应的减少与总lgE水平提高和过敏性鼻炎的加重相关

2019-05-22

科室
- - 订阅+
  - 更多科室
工具
服务